Intelligent Bone Graft System

Publication ID: 24-11857698_0008_PTD

Published: October 28, 2025

Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Bone Graft System,” Published Technical Disclosure No. 24-11857698_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857698_0008_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,698.

Summary of the Inventive Concept

A novel, synergistic system combining silicate-based bone graft substitutes with cutting-edge technologies like AI, IoT, blockchain, and advanced materials to enhance bone growth, monitoring, and treatment outcomes.

Background and Problem Solved

The original bone graft system patent, while providing a bioactive bone graft substitute, has limitations in terms of real-time monitoring, personalized treatment, and supply chain transparency. The new inventive concept addresses these limitations by integrating distinct technologies to create a more powerful and effective system.

Detailed Description of the Inventive Concept

The Intelligent Bone Graft System consists of a silicate-based material integrated with a sensor network utilizing IoT technology to monitor and optimize bone growth in real-time. Additionally, the system incorporates AI-driven analysis of patient data and 3D printing of customized silicate-based implants for personalized bone grafting. A blockchain-based platform ensures secure and transparent tracking of bone graft substitutes from production to implantation, guaranteeing authenticity and quality control. Furthermore, the system can utilize composite materials infused with graphene and integrated with micro-electro-mechanical systems (MEMS) for enhanced mechanical properties and real-time monitoring. The hybrid system combines silicate-based bone graft substitutes with stem cell therapy and AI-assisted monitoring of treatment outcomes.

Novelty and Inventive Step

The new claims introduce a synergistic combination of distinct technologies, creating a novel and non-obvious system that surpasses the original patent's capabilities. The integration of AI, IoT, blockchain, and advanced materials provides a significant inventive step, enabling real-time monitoring, personalized treatment, and enhanced bone growth.

Alternative Embodiments and Variations

Alternative embodiments of the Intelligent Bone Graft System could include the use of different materials, such as ceramics or polymers, instead of silicates. The system could also be adapted for use in various medical applications, including orthopedic, dental, or maxillofacial implants. Furthermore, the AI-driven analysis could be expanded to incorporate additional data sources, such as genomic or proteomic data, to enhance personalized treatment.

Potential Commercial Applications and Market

The Intelligent Bone Graft System has significant commercial potential in the medical device industry, particularly in the orthopedic and dental implant markets. The system's ability to provide real-time monitoring, personalized treatment, and enhanced bone growth could revolutionize the industry, providing a competitive edge for companies that adopt this technology.

CPC Classifications

Section	Class	Group
A	A61	A61L27/40
A	A61	A61L27/425
A	A61	A61L27/427
A	A61	A61L27/52
A	A61	A61L27/56
A	A61	A61L2430/02

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Biomedical engineering, specifically bone graft substitutes and medical device technologies with a focus on orthopedic and dental implant systems

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or materials scientist with expertise in biomaterials, medical device design, advanced manufacturing techniques, and interdisciplinary medical technology integration, holding at least a Master's degree with 3-5 years of specialized experience

Obviousness Rationale

A PHOSITA would recognize that the Intelligent Bone Graft System represents a predictable combination of known technologies in medical device design, where integrating sensor networks, AI, and advanced materials with existing silicate-based bone graft substitutes is a logical extension of current biomedical engineering practices. The proposed variations leverage standard technological convergence strategies common in medical innovation, applying well-established interdisciplinary approaches to enhance existing bone graft technologies. The technical modifications represent incremental improvements using standard engineering design methodologies.

Obvious Combinations & Variations

Source Patent Element

Silicate-based bone graft substitute with porous structure and metal cation incorporation

PTD Variation

Integration of IoT sensor networks for real-time bone growth monitoring

Obviousness Reasoning

Adding sensor monitoring to biomaterials is a predictable enhancement in medical device design, representing a known technique for improving diagnostic capabilities of implantable materials

Source Patent Element

Bone graft substitute with specific material composition

PTD Variation

3D printing of customized silicate-based implants using patient-specific data

Obviousness Reasoning

Personalized manufacturing of medical implants is a well-established trend in biomedical engineering, representing an obvious application of additive manufacturing technologies to existing material compositions

Source Patent Element

Silicate network with incorporated metal cations

PTD Variation

Graphene-infused composite materials with integrated MEMS for enhanced mechanical properties

Obviousness Reasoning

Material enhancement through composite strategies and embedded sensing technologies are standard approaches in materials engineering, representing predictable improvements to existing bone graft substitute designs

Source Patent Element

Bone graft substitute with porous silicate structure

PTD Variation

Blockchain-based tracking and authentication of bone graft substitutes

Obviousness Reasoning

Implementing supply chain and authentication technologies is a routine extension of medical device management practices, representing a logical application of emerging digital technologies

Source Patent Element

Bone graft substitute for orthopedic applications

PTD Variation

Integration of stem cell therapy with AI-assisted treatment monitoring

Obviousness Reasoning

Combining regenerative medicine techniques with advanced monitoring represents a predictable convergence of established medical technologies, following standard interdisciplinary innovation strategies

35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857698 and the disclosed technological variations, a person of ordinary skill in the art would find the proposed Intelligent Bone Graft System claims obvious, as they represent predictable combinations of known medical device technologies, material science techniques, and digital monitoring strategies, thereby rendering subsequent patent claims anticipated and non-patentable under 35 U.S.C. § 103.

Original Patent Information

Patent Number	US 11,857,698
Title	Bone graft system
Assignee(s)	UCL BUSINESS LTD